Q4 2024 Earnings Call Transcript March 31, 2025 Cytosorbents Corporation beats earnings expectations. Reported EPS is $-0.03, ...
Good single releases, more than not, lead to great albums. Goldmine highlights a recent handful from the first quarter of 2025 that should be on your radar ...
Cytosorbents Corporation (CTSO) reports 25% Q4 revenue growth, strong margins, and updates on FDA-reviewed DrugSorb-ATR launch.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback